MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+2.41%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$513M
AUM Growth
+$513M
(-13%)
Cap. Flow
-$71.3M
Cap. Flow
% of AUM
-13.9%
Top 10 Holdings %
Top 10 Hldgs %
16.18%
Holding
249
New
34
Increased
45
Reduced
100
Closed
55
Top Buys
| 1 |
Magnolia Oil & Gas
MGY
|
$6.81M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.78M |
| 3 |
Cadence Bank
CADE
|
$6.49M |
| 4 |
Tidewater
TDW
|
$6.46M |
| 5 |
Vita Coco
COCO
|
$5.59M |
Top Sells
| 1 |
SharkNinja
SN
|
$10.1M |
| 2 |
Cohen & Steers
CNS
|
$9.41M |
| 3 |
BWX Technologies
BWXT
|
$8.47M |
| 4 |
STAG Industrial
STAG
|
$6.59M |
| 5 |
Permian Resources
PR
|
$6.56M |
Sector Composition
| 1 | Healthcare | 17.37% |
| 2 | Industrials | 16.23% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 13.64% |
| 5 | Technology | 13.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Illinois Tool Works
ITW
$76.2B
| – | – |
-782
| Closed | -$210K |
|
227
Intuitive Surgical
ISRG
$158B
| – | – |
-700
| Closed | -$279K |
|
228
IQVIA
IQV
$31.4B
| – | – |
-1,878
| Closed | -$475K |
|
229
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-224,831
| Closed | -$3.33M |
|
230
Incyte
INCY
$17B
| – | – |
-5,433
| Closed | -$310K |
|
231
Helen of Troy
HELE
$595M
| – | – |
-51,518
| Closed | -$5.94M |
|
232
Gilead Sciences
GILD
$140B
| – | – |
-5,858
| Closed | -$429K |
|
233
Exact Sciences
EXAS
$9.33B
| – | – |
-6,059
| Closed | -$418K |
|
234
Elevance Health
ELV
$72.4B
| – | – |
-528
| Closed | -$274K |
|
235
DexCom
DXCM
$30.9B
| – | – |
-2,149
| Closed | -$298K |
|
236
Walt Disney
DIS
$211B
| – | – |
-1,651
| Closed | -$202K |
|
237
Cencora
COR
$57.2B
| – | – |
-1,056
| Closed | -$257K |
|
|
238
Cohen & Steers
CNS
$3.64B
| – | – |
-122,345
| Closed | -$9.41M |
|
239
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-14,687
| Closed | -$616K |
|
240
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-7,049
| Closed | -$616K |
|
241
Biogen
BIIB
$20.8B
| – | – |
-2,901
| Closed | -$626K |
|
242
Biohaven
BHVN
$1.71B
| – | – |
-30,547
| Closed | -$1.67M |
|
243
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-6,431
| Closed | -$378K |
|
244
Amgen
AMGN
$153B
| – | – |
-3,202
| Closed | -$910K |
|
245
Altimmune
ALT
$325M
| – | – |
-307,318
| Closed | -$3.13M |
|
246
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-2,138
| Closed | -$320K |
|
247
Akamai
AKAM
$11.1B
| – | – |
-2,000
| Closed | -$218K |
|
248
Cigna
CI
$80.2B
| – | – |
-957
| Closed | -$348K |
|
249
Braze
BRZE
$2.85B
| – | – |
-40,369
| Closed | -$1.79M |
|